NPS+ Rheumatoid Arthritis (US)
本報告基於以美國的100名的風濕醫生為對象所進行的調查結果，彙整醫生對類風濕性關節炎的領導品牌藥的利用趨勢及各種見解，以支援改善測試客戶忠誠度的NPS (淨推薦值) 指標。
Are US rheumatologists satisfied with the rheumatoid arthritis (RA) treatments on the market? How loyal are they to your brand? How likely are they to switch? And how can you use that information to improve your brand's health?
Find out, and get answers to other important questions for RA brands in FirstView's NPS+ Rheumatoid Arthritis report.
Building on the highly respected net promoter score (NPS), the report gives you a detailed view of how brand loyalty and rheumatologists' recommendation affect your market share. Plus it explores how doctors perceive your brand, and shows you which promotional messages drive the most recommendations.
NPS+ Rheumatoid Arthritis explores key issues affecting brand loyalty for RA drug manufacturers. You'll learn:
Results are presented in clear, intuitive KPIs that highlight areas where your brand can improve, and make it easy to see what your next steps are.
We surveyed 100 US rheumatologists, chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines "brand DNA", revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.